Flurina Böhi

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 5

Top Topics

Inflammatory Response

Mesenchymal Stem Cells

Top Venues

Proceedings of the National Academy of Sciences of the United States of America

Cancer research

This page only lists publications with an associated author ORCID identifier.

Publications

Flurina Böhi, Michael O Hottiger
Expanding the Perspective on PARP1 and Its Inhibitors in Cancer Therapy: From DNA Damage Repair to Immunomodulation. Biomedicines 12 (7) (2024)
Flurina Böhi, Michael O Hottiger
Expanding the Perspective on PARP1 and Its Inhibitors in Cancer Therapy: From DNA Damage Repair to Immunomodulation. Biomedicines 12 (7) (2024)
Flurina Böhi, Michael O Hottiger
Expanding the Perspective on PARP1 and Its Inhibitors in Cancer Therapy: From DNA Damage Repair to Immunomodulation. Biomedicines 12 (7) (2024)
Patrick Manetsch, Flurina Böhi, Kathrin Nowak, Deena M Leslie Pedrioli, Michael O Hottiger
PARP7-mediated ADP-ribosylation of FRA1 promotes cancer cell growth by repressing IRF1- and IRF3-dependent apoptosis. Proceedings of the National Academy of Sciences of the United States of America 120 (49) (2023)
Lorenza P Ferretti, Flurina Böhi, Deena M Leslie Pedrioli, Phil Fang Cheng, Elena Ferrari, Petra Baumgaertner, Abdiel Alvarado-Diaz, Federica Sella, Alessandra Cereghetti, Patrick Turko, Roni H G Wright, Katrien De Bock, Daniel E Speiser, Roberto Ferrari, Mitchell Paul Levesque, Michael O Hottiger
Combinatorial treatment with PARP and MAPK inhibitors overcomes phenotype switch-driven drug resistance in advanced melanoma. Cancer research (2023)